Multidimensional response of Dupilumab in a child affected by Netherton syndrome: Improvement of trichorrhexis invaginata
Pediatr Allergy Immunol
.
2023 Jul;34(7):e13997.
doi: 10.1111/pai.13997.
Authors
Carla Mastrorilli
1
,
Francesca Ambrogio
2
,
Francesco La Torre
1
,
Caterina Foti
2
,
Domenico Bonamonte
2
,
Cristina Serio
1
,
Fabio Cardinale
1
Affiliations
1
Pediatric Department, Pediatric Hospital Giovanni XXIII, Azienda Ospedaliero-Universitaria Policlinic of Bari, Bari, Italy.
2
Unit of Dermatology, Department of Precision and Regenerative Medicine and Ionian Area, University of Bari Aldo Moro, Bari, Italy.
PMID:
37492914
DOI:
10.1111/pai.13997
No abstract available
Publication types
Letter
MeSH terms
Antibodies, Monoclonal, Humanized / therapeutic use
Child
Dermatitis, Exfoliative*
Humans
Netherton Syndrome* / drug therapy
Substances
dupilumab
Antibodies, Monoclonal, Humanized